¿A quién beneficia el comercio paralelo de medicamentos en la Unión Europea?
Year of publication: |
2009
|
---|---|
Authors: | Costa-Font, Joan ; Kanavos, Panos |
Published in: |
El trimestre económico. - Mexico : Fondo, ISSN 0041-3011, ZDB-ID 208477-6. - Vol. 76.2009, 2, p. 331-347
|
Subject: | Arzneimittel | Pharmaceuticals | Grauer Markt | Grey market | EU-Staaten | EU countries |
-
Granlund, David, (2016)
-
Birg, Laura, (2019)
-
Parallel trade and reimbursement regulation
Birg, Laura, (2015)
- More ...
-
¿A quién beneficia el comercio paralelo de medicamentos en la Unión Europea?
Costa-Font, Joan, (2009)
-
Pharmaceutical parallel trade in Europe: stakeholder and competition effects
Kanavos, Panos, (2005)
-
Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia
Costa-Font, Joan, (2007)
- More ...